Combating multidrug-resistant Gram-negative bacterial infections.
about
The spread of carbapenemase-producing bacteria in Africa: a systematic reviewPolyamino-Isoprenic Derivatives Block Intrinsic Resistance of P. aeruginosa to Doxycycline and Chloramphenicol In VitroArt-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosaBactericidal monoclonal antibodies specific to the lipopolysaccharide O antigen from multidrug-resistant Escherichia coli clone ST131-O25b:H4 elicit protection in mice.Escherichia coli ASKA Clone Library Harboring tRNA-Specific Adenosine Deaminase (tadA) Reveals Resistance towards Xanthorrhizol.Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).Six years of a national antimicrobial stewardship programme in Scotland: where are we now?Target-Agnostic Identification of Functional Monoclonal Antibodies Against Klebsiella pneumoniae Multimeric MrkA Fimbrial Subunit.One-Step Synthesis of Silver Nanoparticle-Decorated Hydroxyapatite Nanowires for the Construction of Highly Flexible Free-Standing Paper with High Antibacterial Activity.New Structural Templates for Clinically Validated and Novel Targets in Antimicrobial Drug Research and Development.Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection.Carbon nanotubes as anti-bacterial agents.Chloramphenicol - A Potent Armament Against Multi-Drug Resistant (MDR) Gram Negative Bacilli?Branched Peptide, B2088, Disrupts the Supramolecular Organization of Lipopolysaccharides and Sensitizes the Gram-negative Bacteria.A unique peptide deformylase platform to rationally design and challenge novel active compounds.Targeted localized use of therapeutic antibodies: a review of non-systemic, topical and oral applications.Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers.Characterization and genome sequencing of a Citrobacter freundii phage CfP1 harboring a lysin active against multidrug-resistant isolates.Bacterial imaging and photodynamic inactivation using zinc(II)-dipicolylamine BODIPY conjugates.The Stories Tryptophans Tell: Exploring Protein Dynamics of Heptosyltransferase I from Escherichia coli.Fluorescent Trimethoprim Conjugate Probes To Assess Drug Accumulation in Wild Type and Mutant Escherichia coliTarget-based resistance in Pseudomonas aeruginosa and Escherichia coli to NBTI 5463, a novel bacterial type II topoisomerase inhibitor.Novel Group of Leaderless Multipeptide Bacteriocins from Gram-Positive Bacteria.A lytic Providencia rettgeri virus of potential therapeutic value is a deep-branching member of the T5virus genus.The Multidrug-Resistant Gram-negative Superbugs Threat Require Intelligent Use of the Last WeaponNovel pyochelin-based PEGylated liposomes for enhanced delivery of antibiotics against resistant clinical isolates of Pseudomonas aeruginosa.Ion mobility coupled to native mass spectrometry as a relevant tool to investigate extremely small ligand-induced conformational changes.Tristemma hirtum and Five Other Cameroonian Edible Plants with Weak or No Antibacterial Effects Modulate the Activities of Antibiotics against Gram-Negative Multidrug-Resistant Phenotypes.Environmental monitoring of bacterial contamination and antibiotic resistance patterns of the fecal coliforms isolated from Cauvery River, a major drinking water source in Karnataka, India.
P2860
Q27000635-AB91B623-744F-49DE-B186-E4C9F373E95CQ28551861-4C452131-D76D-4633-B282-0977120D7AF7Q30581467-1D1A0BE4-59FA-47D2-981C-D68C673E2733Q35607916-025A3AEE-5360-4A40-A0BE-DB36C18DFBB2Q35775522-C1EC60D8-7C19-476E-A2AF-3A4423AAA65FQ35840246-96086193-D2BD-47CD-8320-4CD28C231F8BQ35856731-4E10BA63-CA32-4B2A-9CD3-A7C8FA3CFEBAQ35894482-FBF8CC24-856D-491F-A49D-889252E6D795Q36062192-90C42B61-4147-48BC-8D98-1534D3E7CE8EQ36153263-EED9C0CE-170B-4190-AC76-9A2B882FAAA0Q36225173-670ACA63-88E8-48B2-89AC-8605840DDC34Q36378952-2A5F6832-1F9E-4F38-B201-ABA0D1B0D793Q36708456-D37FC51A-5F5A-4C00-B3B1-8F1E544391C4Q36897919-A21DEDB8-8FE5-4553-AC65-4813914E3F57Q37352732-5ECD9AFA-631F-4948-958B-DBC9459FE49EQ38323786-A9B6B880-C8FE-40ED-AA41-712F867E69B4Q40485776-74709AD9-2B53-4151-A42C-5BFEE0F2528BQ40523546-3181AC6E-D43A-4A1F-A8B2-EA7C2D44F9D8Q41170348-41CD24BE-B0FF-4974-B220-E6547239DBC6Q41278088-7696024A-FA04-44A1-94A4-77ED894C9C4FQ41484434-2F557EF2-77D6-48E2-8BD9-5117221C4C0EQ41687386-C50DDFEE-1016-44F9-AA52-F17D2ABF4BB3Q41717646-894E2760-3154-4EA0-B8F8-4DB19CD58F69Q41931850-A53C4433-3F25-457C-AC54-B7065B0D1F33Q42323401-19EA8B94-3C09-4057-B5D6-411801056861Q48229487-AAA7CE7B-7E48-4620-993E-1FD14F300ED0Q53339732-D1AA9BB2-1A85-4508-A848-E4D18E0C43C6Q54210700-B235AB40-4C38-4C33-99E1-A22B3EA847D5Q54270099-E52CE64D-659E-4062-9817-54675FBE01F2
P2860
Combating multidrug-resistant Gram-negative bacterial infections.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Combating multidrug-resistant Gram-negative bacterial infections.
@en
type
label
Combating multidrug-resistant Gram-negative bacterial infections.
@en
prefLabel
Combating multidrug-resistant Gram-negative bacterial infections.
@en
P2093
P2860
P1476
Combating multidrug-resistant Gram-negative bacterial infections.
@en
P2093
John Flavin
Michael T Flavin
P2860
P304
P356
10.1517/13543784.2014.848853
P407
P577
2013-11-11T00:00:00Z